IP Library Granted Patent US 12,396,840
Granted Patent B2
US 12,396,840 · App. 18/204,087 · Granted Aug 26, 2025

Breast implants with integrated transponders

Inventors: Ezequiel Mejia (Woodbury, MN); Randolph Keith Geissler (Minneapolis, MN); Juan José Chacón Quirós (Alajuela, CR)
Assignee: Establishment Labs S.A.
A61F2/12B29C41/02B29C41/14A61F2240/001A61F2250/0096B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,396,840
App. No.
18/204,087
Granted
Aug 26, 2025
Kind
B2
Abstract

The present disclosure provides, in various examples, an implant with a transponder embedded therein, and a method of identifying the implant while inside the human body. In certain examples, the method includes, for example, identifying an implant with an external reader and establishing a wireless communication between the external reader and the transponder. In an example, the implant is identified using information obtained during the wireless communication.

Claims (53)

1. A method of identifying an implant, the method comprising:

locating an external reader near the implant, the implant including:

a shell having one or more layers surrounding a cavity;

a filler disposed within the cavity;

an opening extending through the shell and into the cavity;

a patch disposed on an outermost surface of the shell, the patch configured to cover the opening; and

a transponder unconnected to the shell, disposed within the cavity and flexibly fixed within the filler, the transponder spaced from the patch and proximate to the patch;

establishing wireless communication between the external reader and the transponder; and

identifying the implant using information obtained during the wireless communication.

2. The method of identifying the implant of claim 1 , comprising:

accessing one or more databases containing identification information.

3. The method of identifying the implant of claim 1 , wherein establishing the wireless communication between the external reader and the transponder includes communicating a unique identification code from the transponder to an external reader;

wherein the transponder is disposed within a gel in the implant.

4. The method of identifying the implant of claim 3 , wherein the filler includes a silicone gel.

5. The method of identifying the implant of claim 1 , wherein establishing the wireless communication includes establishing communication between the external reader and the transponder, the transponder positioned closer to a posterior side of the implant than an anterior side of the implant.

6. The method of identifying the implant of claim 1 , wherein the transponder is sized to fit through the opening extending through the shell.

7. The method of identifying the implant of claim 1 , wherein the patch is on a posterior side of the implant.

8. A method of identifying an implant located in a body, the method comprising:

locating the implant with an external reader, the implant including:

a multilayered shell surrounding a cavity;

a transponder positioned in the cavity of the implant;

a filler disposed within the cavity;

wherein the transponder is unconnected to the multilayered shell, suspended and secured within the filler; and

a patch disposed on the shell;

wherein the transponder is spaced from the patch;

wherein the transponder is proximate to the patch;

establishing communication between an external reader and the transponder; and

identifying the implant using information communicated to the external reader.

9. The method of identifying the implant of claim 8 , further comprising:

accessing one or more databases containing identification information to identify the implant.

10. The method of identifying the implant of claim 8 ,

wherein the transponder is configured to be implanted in the cavity concurrently with filling the cavity.

11. The method of identifying the implant of claim 8 , wherein the filler includes a silicone gel.

12. The method of identifying the implant of claim 8 , wherein the transponder is an RFID transponder.

13. The method of identifying the implant of claim 8 , wherein the patch is located on a posterior side of the implant.

14. The method of identifying the implant of claim 13 , wherein the transponder is located closer to the posterior side of the implant than an anterior side of the implant.

15. The method of identifying the implant of claim 8 , wherein the implant is a breast implant.

16. The method of identifying the implant of claim 8 , wherein the external reader includes a handheld scanner.

17. The method of identifying the implant of claim 8 , wherein the filler is configured to be cured.

18. A system for identifying an implant, the system comprising:

an external reader configured to locate the implant, the implant including:

a multilayered shell forming a cavity;

a filler disposed within the cavity;

an aperture formed in back side of the multilayered shell;

a patch positioned over the aperture; and

a transponder unconnected to the multilayered shell, and suspended and flexibly fixed in the filler;

wherein the transponder is flexibly fixed within the filler proximate to the patch;

the external reader configured to read information contained on the transponder; and

a computer configured to receive communication from the external reader, the computer including:

a processor; and

a database containing information about the implant.

19. The system for identifying the implant of claim 18 , wherein the transponder is located closer to a posterior side of the implant than an anterior side.

20. The system for identifying the implant of claim 18 , wherein the implant is a breast implant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2025
From: JAMM TECHNOLOGIES, INC.
To: ESTABLISHMENT LABS S.A.
Reel/Frame 070548/0240 →
Continuity (5)
Continuation 16832149 · Mar 27, 2020
Continuation 15868414 · Jan 11, 2018
Continuation 14028193 · Sep 16, 2013
Provisional Application 61701910 · Sep 17, 2012
Related Publication 20230301772A1 · Sep 28, 2023
References Cited (119)
US 4863470A · Carter · 1989 [cited by examiner]
US 5300120A · Knapp et al. · 1994 [cited by applicant]
US 5545220A · Andrews et al. · 1996 [cited by applicant]
US 5653758A · Daniels et al. · 1997 [cited by applicant]
US 5674288A · Knapp et al. · 1997 [cited by applicant]
US 5716407A · Knapp et al. · 1998 [cited by applicant]
US 5725578A · Knapp et al. · 1998 [cited by applicant]
US 5824081A · Knapp et al. · 1998 [cited by applicant]
US 5833603A · Kovacs et al. · 1998 [cited by applicant]
US 5855609A · Knapp · 1999 [cited by applicant]
US 5977431A · Knapp et al. · 1999 [cited by applicant]
US 8042738B2 · Cloix · 2011 [cited by applicant]
US 8764825B2 · Ledergerber · 2014 [cited by applicant]
US 9132004B2 · Yu · 2015 [cited by examiner]
US 9901438B2 · Mejia et al. · 2018 [cited by applicant]
US 10052190B2 · Chitre · 2018 [cited by examiner]
US 10588737B2 · Mcclellan · 2020 [cited by examiner]
US 10631976B2 · Mejia et al. · 2020 [cited by applicant]
US 11160630B2 · Schuessler · 2021 [cited by examiner]
US 11701219B2 · Mejia et al. · 2023 [cited by applicant]
US 20060069403A1 · Shalon · 2006 [cited by examiner]
US 20060111777A1 · Chen · 2006 [cited by examiner]
US 20070239016A1 · Fisher · 2007 [cited by examiner]
US 20080048855A1 · Berger · 2008 [cited by examiner]
US 20080270985A1 · Mccormack et al. · 2008 [cited by applicant]
US 20080275327A1 · Faarbaek · 2008 [cited by examiner]
US 20090012372A1 · Burnett et al. · 2009 [cited by applicant]
US 20090043177A1 · Milledge · 2009 [cited by examiner]
US 20090149953A1 · Schuessler · 2009 [cited by examiner]
US 20090270985A1 · Schuessler · 2009 [cited by examiner]
US 20100049316A1 · Schuessler · 2010 [cited by applicant]
US 20100094416A1 · Maguire · 2010 [cited by examiner]
US 20100194541A1 · Stevenson · 2010 [cited by examiner]
US 20100228347A1 · Schuessler · 2010 [cited by applicant]
US 20110029076A1 · Paletta et al. · 2011 [cited by applicant]
US 20110046729A1 · Schuessler · 2011 [cited by examiner]
US 20110098576A1 · Hollstien · 2011 [cited by examiner]
US 20110137413A1 · Osypka · 2011 [cited by applicant]
US 20110257743A1 · Schuessler · 2011 [cited by applicant]
US 20120165934A1 · Schuessler · 2012 [cited by applicant]
US 20120302874A1 · Hollstien · 2012 [cited by examiner]
US 20130013063A1 · Del Vecchio · 2013 [cited by applicant]
US 20130131800A1 · Schuessler · 2013 [cited by applicant]
US 20130338769A1 · Boyden et al. · 2013 [cited by applicant]
US 20130338772A1 · Boyden · 2013 [cited by examiner]
US 20140081398A1 · Mejia et al. · 2014 [cited by applicant]
US 20160101281A1 · Chen · 2016 [cited by examiner]
US 20180036115A1 · Smirnov · 2018 [cited by examiner]
US 20180200043A1 · Mejia et al. · 2018 [cited by applicant]
US 20190038496A1 · Levesque · 2019 [cited by examiner]
US 20190142574A1 · Quirós · 2019 [cited by examiner]
US 20190192280A1 · Govari · 2019 [cited by examiner]
US 20200323624A1 · Mejia et al. · 2020 [cited by applicant]
US 20200352704A1 · Schuessler · 2020 [cited by examiner]
US 20240122480A1 · Kim · 2024 [cited by examiner]
BR 112015005695A2 · 2017 [cited by applicant]
BR 112015005695B1 · 2021 [cited by applicant]
EP 2895109A1 · 2015 [cited by applicant]
EP 2895109B1 · 2019 [cited by applicant]
EP 3479796A1 · 2019 [cited by applicant]
EP 3479796B1 · 2020 [cited by applicant]
EP 3831341A1 · 2021 [cited by applicant]
ES 2721007T3 · 2019 [cited by applicant]
HK 40044710 · 2021 [cited by applicant]
WO WO9404094A1 · 1994 [cited by examiner]
WO WO9622058A1 · 1996 [cited by applicant]
WO WO2008014283A2 · 2008 [cited by applicant]
WO WO2008043921A2 · 2008 [cited by applicant]
WO WO2008055229A2 · 2008 [cited by applicant]
WO WO2010056610A2 · 2010 [cited by applicant]
WO WO2014047013A1 · 2014 [cited by applicant]
WO WO2017137853A2 · 2017 [cited by applicant]
WO WO2021101232A1 · 2021 [cited by examiner]
U.S. Appl. No. 15/868,414 U.S. Pat. No. 10,631,976, filed Jan. 11, 2018, Method of Manufacturing Breast Implants With Integrated Transponders. [cited by applicant]
U.S. Appl. No. 14/028,193 U.S. Pat. No. 9,901,438, filed Sep. 16, 2013, Method of Manufacturing Breast Implants With Integrated Transponders. [cited by applicant]
U.S. Appl. No. 16/832,149, filed Mar. 27, 2020, Breast Implants With Integrated Transponders. [cited by applicant]
“U.S. Appl. No. 14/028,193, Examiner Interview Summary mailed Jul. 6, 2017”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Final Office Action mailed Apr. 10, 2017”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Non Final Office Action mailed Oct. 8, 2015”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Notice of Allowance mailed Oct. 12, 2017”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Response filed Apr. 8, 2016 to Non Final Office Action mailed Oct. 8, 2015”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Response filed Jul. 28, 2015 to Restriction Requirement mailed May 5, 2015”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Response filed Sep. 12, 2016 to Non Final Office Action mailed Oct. 8, 2015”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Response filed Sep. 25, 2017 to Final Office Action mailed Apr. 10, 2017”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 14/028,193, Restriction Requirement mailed May 5, 2015”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/868,414, Non Final Office Action mailed Jul. 29, 2019”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 15/868,414, Notice of Allowance mailed Dec. 27, 2019”, 8pgs. [cited by applicant]
“U.S. Appl. No. 15/868,414, Preliminary Amendment filed Jan. 11, 2018”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/868,414, Response filed Nov. 27, 2019 to Non Final Office Action mailed Jul. 29, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/868,414, Supplemental Preliminary Amendment filed Apr. 5, 2018”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/832,149, Non Final Office Action mailed Jun. 20, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/832,149, Notice of Allowance mailed Mar. 1, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/832,149, Preliminary Amendment filed Mar. 27, 2020”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/832,149, Response filed Sep. 20, 2022 to Non Final Office Action malled Jun. 20, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/832,149, Supplemental Notice of Allowability mailed May 17, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/832,149, Supplemental Preliminary Amendment filed Jul. 8, 2020”, 6 pgs. [cited by applicant]
“Brazilian Application Serial No. BR112015005695-4, Office Action mailed Mar. 3, 2021”, w/ English Machine Translation, 8 pgs. [cited by applicant]
“Brazilian Application Serial No. BR112015005695-4, Office Action mailed Aug. 20, 2021”, w/ English Machine Translation, 6 pgs. [cited by applicant]
“Brazilian Application Serial No. BR112015005695-4, Office Action mailed Nov. 4, 2019”, w/ English Machine Translation, 8 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Communication Pursuant to Article 94(3) EPC mailed Apr. 19, 2018”, 4 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Communication Pursuant to Article 94(3) EPC mailed Aug. 16, 2017”, 4 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Decision to Grant mailed Dec. 20, 2018”, 2 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Extended European Search Report mailed Apr. 8, 2016”, 9 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Intention to Grant mailed Jul. 23, 2018”, 30 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Response filed Feb. 23, 2018 to Communication Pursuant to Article 94(3) EPC mailed Aug. 16, 2017”, 12 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Response filed Jun. 26, 2018 to Communication Pursuant to Article 94(3) EPC mailed Apr. 19, 2018”, 8 pgs. [cited by applicant]
“European Application Serial No. 13839796.3, Response filed Nov. 4, 2016 to Extended European Search Report mailed Apr. 8, 2016”, 16 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Communication Pursuant to Article 94(3) EPC mailed Aug. 30, 2019”, 3 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Decision to Grant mailed Nov. 26, 2020”, 2 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Extended European Search Report mailed Apr. 4, 2019”, 5 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Intention to Grant mailed Feb. 26, 2020”, 18 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Intention to Grant mailed Jul. 6, 2020”, 18 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Response filed Jan. 9, 2020 to Communication Pursuant to Article 94(3) EPC mailed Aug. 30, 2019”, 16 pgs. [cited by applicant]
“European Application Serial No. 18210589.0, Response filed May 19, 2020 to Intention to Grant mailed Feb. 26, 2020”, 3 pgs. [cited by applicant]
“European Application Serial No. 20216184.0, Extended European Search Report mailed May 3, 2021”, 8 pgs. [cited by applicant]
“European Application Serial No. 20216184.0, Response filed Dec. 8, 2021 to Extended European Search Report mailed May 3, 2021”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2013/059988, International Preliminary Report on Patentability malled Mar. 26, 2015”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2013/059988, International Search Report mailed Dec. 5, 2013”, 3 pgs. [cited by applicant]
“International Application Serial No. PCT/US2013/059988, Written Opinion mailed Dec. 5, 2013”, 5 pgs. [cited by applicant]